Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05866328
Other study ID # ULaguna
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 13, 2019
Est. completion date January 10, 2022

Study information

Verified date June 2023
Source University of La Laguna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized controlled trial. Sixty-five participants (83% with schizophrenia or bipolar disorder) were recruited from community mental health teams. Fifty-seven met criteria and agreed to participate in the study. The conditions of cognitive rehabilitation were assigned randomly with support employment CR + IPS (n = 28) and IPS alone (n = 29). Cogpack program was used. Two groups were followed at 8 and 12 months after the baseline.


Description:

This work was developed in the island of Tenerife (Spain) within a public service specialised in labour integration of people with disabilities in which an IPS team was set up in 2005. The study was carried out in collaboration with the units of community mental health of the island. These units carry out the control of people with serious mental illnesses including pharmacological treatment and psychosocial programming. All research procedures were approved by the Medicine Committee of Canary Health Services. The follow-up period for the data collection was set between 2013 and 2014. Employment specialists belong to a public institution specialized in work disability.Sixty-five participants but only 57 signed written informed consent and completed the baseline. Two groups were assigned randomly:one with support employment and cognitive rehabilitation the second group with IPS alone


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 10, 2022
Est. primary completion date October 18, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: Participants had to: 1. comply with the state definitions of severe mental illness (SMI), which includes an ICD-10 (World Health Organization, 1992) diagnosis of F20- 29 (schizophrenia, schizotypal, delusional and other non-mood psychotic disorders) and F31-F32.3 (major mood affective disorders) 2. have previous difficulties to maintain a job 3. currently want a competitive job and 4. accept the job search starts Exclusion Criteria: People with no Severe mental illness and not want to participate

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive Rehabilitation and Individual Placement and Support
Cognitive Rehabilitation and Individual Placement and Support

Locations

Country Name City State
Spain Francisco Rodriguez Pulido La Laguna Santa CRUZ DE Tenerife

Sponsors (2)

Lead Sponsor Collaborator
University of La Laguna University of Santiago de Compostela

Country where clinical trial is conducted

Spain, 

References & Publications (2)

Marono Souto Y, Vazquez Campo M, Diaz Llenderrozas F, Rodriguez Alvarez M, Mateos R, Garcia Caballero A. Randomized Clinical Trial with e-MotionalTraining(R) 1.0 for Social Cognition Rehabilitation in Schizophrenia. Front Psychiatry. 2018 Feb 26;9:40. doi — View Citation

Vazquez-Campo M, Marono Y, Lahera G, Mateos R, Garcia-Caballero A. e-Motional Training(R): Pilot study on a novel online training program on social cognition for patients with schizophrenia. Schizophr Res Cogn. 2016 Mar 12;4:10-17. doi: 10.1016/j.scog.201 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Ekman 60 Faces Test total score changes Minimum 0 and maximum 60. Between 20-40 years average 51.43, cut-off point 45, below deficit. Between 40-60 years, average 51.20, cut-off point 43, below deficit. At baseline and after 1 year treatment
Primary Hinting Task total score changes Total 1 minimum 0 and maximum 20. Total 2 minimum 0 and maximum 10. Cut-off point 18, less deficit. At baseline and after 1 year treatment
Primary Happé Strange Stories Test total score changes Total control minimum 0 and maximum 16. Total theory of mind minimum 0 and maximum 16. Cut-off point 14, below the deficit. At baseline and after 1 year treatment
Primary Faux Pas Recognition Test total score changes FP stories and C questions, C stories and FP questions and C stories and C questions minimum 0 and maximum 20. FP stories and FP questions minimum 0 and maximum 60. Cut-off point without errors 54 and with errors 48, lower deficit scores. At baseline and after 1 year treatment
Primary Ambiguous Intentions and Hostility Questionnaire total score changes Hostility, anger, guilt and aggression minimum 1 and maximum 5. Intentionality minimum 1 and maximum 6. Calculate the mean. At baseline and after 1 year treatment
Primary Movie for the Assessment of Social Cognition total score changes Minimum 0 and maximum 42. At baseline and after 1 year treatment
Primary Screening for Cognitive Impairment in Psychiatry (SCIP-S) total score changes Minimum 1 and maximum 99, very low range 1-2.5 and low range 2.5-15. The deterioration depends on the scale. At baseline and after 1 year treatment
Primary Positive and Negative Symptom Scale (PANSS) total score changes Positive and negative subscales minimum 7 and maximum 49. General psychopathology subscale minimum 16 and maximum 112. Composite subscale minimum -42 and maximum +42. Categorize subtype positive >0 and negative <0. At baseline and after 1 year treatment
Secondary Employment Number of jobs Up to 12 months in 2021
See also
  Status Clinical Trial Phase
Recruiting NCT04406675 - Social Cognition in Patients With Amyotrophic Lateral Sclerosis N/A
Completed NCT02566356 - Adult Study Oxytocin - fMRI Early Phase 1
Active, not recruiting NCT00747396 - The Bucharest Early Intervention Project N/A
Completed NCT02228031 - Oxytocin, Emotions and Mirror Neurons Early Phase 1
Completed NCT02567032 - Adult Study Oxytocin - Behavioral Early Phase 1
Recruiting NCT03035669 - Effects of Mindfulness Training on Emotion Regulation and Social Cognition. N/A
Completed NCT03775564 - Effectiveness of the RemedRugby Program N/A
Not yet recruiting NCT06213194 - The Effects of Executive Functions and Social Cognition on Mental Health N/A
Recruiting NCT05773872 - Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia N/A
Completed NCT05320991 - Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers Phase 4
Recruiting NCT01903915 - Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia N/A
Recruiting NCT05194254 - MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD N/A
Completed NCT00884897 - Oxytocin and Social Cognition in Schizophrenia Phase 2
Completed NCT03450356 - The German Version of the Awareness of Social Inference Test
Not yet recruiting NCT03812913 - Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Completed NCT02568709 - Oxytocin MEG Study Early Phase 1
Completed NCT02652013 - Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis N/A
Completed NCT01616407 - Effects of MDMA and Methylphenidate on Social Cognition Early Phase 1
Completed NCT01206842 - Social Cognition Training in Schizophrenia N/A
Completed NCT02577575 - Adult Oxytocin Study Early Phase 1